Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Lesinurad

Lesinurad (RDEA594) is a selective uric acid reabsorption inhibitor used in combination therapy for gout. Its clinical use has been limited, but it has not been linked to serum enzyme elevations or clinically apparent liver injury. Research applications include in vitro and in vivo studies targeting the URAT1 transporter for hyperuricemia management.

Product Specifications

CAS Number

878672-00-5

Product Name Alternative

Inhibitor, Lesinurad, inhibit, OAT3, OAT1, Urate transporter 1, URAT1, SLC22A12, RDEA 594, RDEA594, RDEA-594

Field of Research

Pharmacology & Drug Discovery

Purity

99.48% (May vary between batches)

Solubility

DMSO:50 mg/mL (123.68 mM) ; Ethanol:50 mg/mL (123.68 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.95 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble)

Smiles

OC (=O) CSc1nnc (Br) n1-c1ccc (C2CC2) c2ccccc12

Molecular Formula

C17H14BrN3O2S

Molecular Weight

404.28

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CTF1 Rabbit pAb
MBS9145805-01 0.02 mL

CTF1 Rabbit pAb

Sign In for Pricing
View Details
CTF1 Rabbit pAb
MBS9145805-02 0.1 mL

CTF1 Rabbit pAb

Sign In for Pricing
View Details
CTF1 Rabbit pAb
MBS9145805-03 5x 0.1 mL

CTF1 Rabbit pAb

Sign In for Pricing
View Details
CAGE1 (NM_205864) Human Over-expression Lysate
LY404212 100 µg

CAGE1 (NM_205864) Human Over-expression Lysate

Sign In for Pricing
View Details
FDA-approved & Passed Phase I Drug Library
C06763-01 100 μL/Well

FDA-approved & Passed Phase I Drug Library

Sign In for Pricing
View Details
FDA-approved & Passed Phase I Drug Library
C06763-02 2x 100 μL/Well

FDA-approved & Passed Phase I Drug Library

Sign In for Pricing
View Details